Conference Coverage
Conference Coverage
Switch to nilotinib improves deep molecular response in CML
©ASCO/Phil McCarten CHICAGO—Patients with chronic myeloid leukemia (CML) are more likely to achieve a deep molecular response if they switch to...
Conference Coverage
Approach can reduce drug-induced TLS
Photo courtesy of EHA MILAN—The BCL-2 inhibitor ABT-199 may be a feasible treatment option for patients with chronic lymphocyctic leukemia/small...
Conference Coverage
CNS involvement predicts relapse but not survival in ARL, study shows
The research showed that ARL patients with CNS involvement at diagnosis were nearly 3 times as likely as their peers to have CNS relapse during...
Conference Coverage
Eltrombopag reduces bleeding in children with chronic immune thrombocytopenia
Key clinical point: Eltrombopag may soon be a treatment option for children with chronic immune thrombocytopenia. Major finding: Platelet response...
Conference Coverage
Imatinib appears safe, effective for the long haul
Key clinical finding: Imatinib is safe and effective for treating patients with chronic myeloid leukemia over the course of a decade. Major...
Conference Coverage
Screen for Barrett’s in all with central obesity?
Key clinical point: The current recommended strategy of screening for Barrett’s esophagus on the basis of symptoms of gastroesophageal reflux is...
Conference Coverage
Ibrutinib holds CLL at bay in majority of patients at 30 months
Major finding: At 30 months of follow-up, overall survival with ibrutinib monotherapy was 96.6% among patients with newly diagnosed chronic...
Conference Coverage
Cream provides relief for leg ulcers in SCD
The cream significantly decreased the size of leg ulcers overall, healed ulcers in 6 of the 18 patients studied, and reduced pain levels,...
Conference Coverage
VIDEO: Team approach is best for successful oncofertility clinic
Conference Coverage
Ensure business associate agreements comply with HIPAA rule, attorneys advise
Conference Coverage
Adding age to stage better predicts adrenocortical carcinoma prognosis
Key clinical point: Adding age to the ENSAT staging system improved prediction of adrenocortical carcinoma prognosis.